4170 related articles for article (PubMed ID: 6597451)
1. Amplification by macrophages of prostaglandin-mediated immunosuppression in mice bearing syngeneic tumors.
Plescia OJ; Pontieri GM; Brown J; Racis S; Ippoliti F; Bellelli L; Sezzi ML; Lipari M
Prostaglandins Leukot Med; 1984 Nov; 16(2):205-23. PubMed ID: 6597451
[TBL] [Abstract][Full Text] [Related]
2. Differential induction of suppressor macrophages by cloned Lewis lung carcinoma variants in mice.
Young MR; Newby M
J Natl Cancer Inst; 1986 Dec; 77(6):1255-60. PubMed ID: 3491925
[TBL] [Abstract][Full Text] [Related]
3. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
Gabizon A; Leibovich SJ; Goldman R
J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
[TBL] [Abstract][Full Text] [Related]
4. Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T lymphocytes and macrophages.
Elgert KD; Farrar WL
J Immunol; 1978 Apr; 120(4):1345-53. PubMed ID: 305939
[TBL] [Abstract][Full Text] [Related]
5. Macrophage-mediated suppression of natural killer cell activity in mice bearing Lewis lung carcinoma.
Young MR; Wheeler E; Newby M
J Natl Cancer Inst; 1986 Apr; 76(4):745-50. PubMed ID: 3457207
[TBL] [Abstract][Full Text] [Related]
6. Modulation of alloreactivity by Mac-1+, -2+, and -3+ macrophages from normal and tumor-bearing hosts: flow cytofluorometrically separated macrophages.
Askew D; Burger CJ; Elgert KD
Immunobiology; 1990 Dec; 182(1):1-10. PubMed ID: 2151512
[TBL] [Abstract][Full Text] [Related]
7. The effect of indomethacin on the activation and effector function of suppressor cells from tumor-bearing mice.
Pope BL
Cancer Immunol Immunother; 1985; 19(2):101-8. PubMed ID: 3157436
[TBL] [Abstract][Full Text] [Related]
8. Suppressor alveolar macrophages in mice bearing metastatic Lewis lung carcinoma tumors.
Young MR; Endicott RA; Duffie GP; Wepsic HT
J Leukoc Biol; 1987 Dec; 42(6):682-8. PubMed ID: 3500255
[TBL] [Abstract][Full Text] [Related]
9. The suppressive effect of peritoneal exudate macrophages on production of antibody to sheep erythrocytes in vitro.
Yoshikai Y; Miake S; Sano M; Nomoto K
Cell Immunol; 1983 Apr; 77(2):266-78. PubMed ID: 6573972
[TBL] [Abstract][Full Text] [Related]
10. Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. II. Mechanisms for induction of suppression.
Ting CC; Hargrove ME
J Natl Cancer Inst; 1982 Oct; 69(4):873-8. PubMed ID: 6214654
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of the reactivity of subpopulations of spleen cells of mice bearing virus-induced mammary tumors to syngeneic antigenic extracts in vitro. Supportive and suppressive effects of macrophages.
Laing CA
Cancer Immunol Immunother; 1982; 13(2):98-104. PubMed ID: 6297714
[TBL] [Abstract][Full Text] [Related]
12. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
Alleva DG; Burger CJ; Elgert KD
Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta (TGF-beta)-mediated immunosuppression in the tumor-bearing state: enhanced production of TGF-beta and a progressive increase in TGF-beta susceptibility of anti-tumor CD4+ T cell function.
Li XF; Takiuchi H; Zou JP; Katagiri T; Yamamoto N; Nagata T; Ono S; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1993 Mar; 84(3):315-25. PubMed ID: 8098027
[TBL] [Abstract][Full Text] [Related]
14. Differential induction of hematopoiesis and immune suppressor cells in the bone marrow versus in the spleen by Lewis lung carcinoma variants.
Young MR; Aquino S; Young ME
J Leukoc Biol; 1989 Mar; 45(3):262-73. PubMed ID: 2522492
[TBL] [Abstract][Full Text] [Related]
15. Tumor-mediated immunosuppression: prevention by inhibitors of prostaglandin synthesis.
Grinwich KD; Plescia OJ
Prostaglandins; 1977; 14(6):1175-82. PubMed ID: 601249
[TBL] [Abstract][Full Text] [Related]
16. Macrophage-derived prostaglandin E modulation of the mixed-lymphocyte reaction: an anomaly of increased production and decreased T-cell susceptibility during tumor growth.
Denbow CJ; Conroy JM; Elgert KD
Cell Immunol; 1984 Mar; 84(1):1-13. PubMed ID: 6230157
[TBL] [Abstract][Full Text] [Related]
17. Cytokines and suppressor macrophages cause tumor-bearing host CD8+ T cells to suppress recognition of allogeneic and syngeneic MHC class II molecules.
Walker TM; Yurochko AD; Burger CJ; Elgert KD
J Leukoc Biol; 1992 Dec; 52(6):661-9. PubMed ID: 1464737
[TBL] [Abstract][Full Text] [Related]
18. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
Fortner GW; Kripke ML
J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
[TBL] [Abstract][Full Text] [Related]
19. Subversion of immune system by tumor cells and role of prostaglandins.
Plescia OJ; Smith AH; Grinwich K
Proc Natl Acad Sci U S A; 1975 May; 72(5):1848-51. PubMed ID: 1057174
[TBL] [Abstract][Full Text] [Related]
20. Activation of suppressor cells by low molecular weight factors secreted by spleen cells of tumor-bearing mice: modulatory role of prostaglandins.
Pillay DJ; Karmazyn M; Pope BL
Int J Immunopharmacol; 1986; 8(2):227-35. PubMed ID: 2940193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
